This exchange-traded fund (ETF) primarily allocates its capital to common equity securities issued by companies globally, irrespective of their market capitalization. Its central investment theme revolves around enterprises driving the "biology revolution," whether they are classified as growth-oriented, value-based, or a blend of both. Periodically, the fund may dedicate a substantial segment of its assets to firms operating within one or more interconnected industries or sectors. These could encompass areas such as healthcare, consumer discretionary, consumer staples, biotechnology, and materials. As a non-diversified fund, its portfolio may exhibit higher concentration.

Thermo Fisher Scientific Inc.

AbbVie Inc.

Corteva, Inc.

NVIDIA Corporation

Ascendis Pharma A/S

Bio-Rad Laboratories, Inc.

AstraZeneca PLC

Eli Lilly and Company

Cadence Design Systems, Inc.

Regeneron Pharmaceuticals, Inc.

Healthcare

Basic Materials

Technology

Consumer Defensive

Consumer Cyclical

Putnam BioRevolution ETF

SYNB Holdings & Sector Breakdown

SYNB Holdings & Sector Breakdown